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Abstract
Purpose: We sought to determine if use of warm fresh whole blood (WFWB), rather than blood
component therapy, alters rates of acute lung injury (ALI) in patients with trauma.
Materials and Methods:We retrospectively analyzed rates of ALI in patients undergoing massive blood
transfusions while at a combat support hospital. Patients with ALI were compared with those not
developing ALI with respect to demographics, trauma type, severity of illness, crystalloid volume given,
and exposure to WFWB. Logistic regression was used to identify variables associated with ALI.
Results: The cohort included 591 subjects (mean age, 28 ± 8.1 years; male, 96.7%). Acute lung injury
occurred in 11.2%, and 34.4% received WFWB. After adjusting for the type of trauma, severity of
illness, and volume of crystalloid administered, WFWB remained independently associated with ALI
(adjusted odds ratio [AOR], 1.06; 95% confidence interval [CI], 1.00-1.13). Nearly two thirds of
persons with ALI never received WFWB; factors associated with the use of WFWB were also
examined. Severity of illness (AOR, 1.18; 95% CI, 1.02-1.35), crystalloid volume (AOR, 1.12; 95% CI,
1.06-1.18), recombinant factor VIIa use (AOR, 1.94; 95% CI, 1.06-3.57), and US citizenship (AOR,
3.06; 95% CI, 1.74-5.37) correlated with WFWB use.
Conclusions: Warm fresh whole blood may be associated with an increased risk of ALI, but this is
confounded by increased injury and crystalloid use in patients receiving WFWB.
© 2012 Elsevier Inc. All rights reserved.
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1. Introduction
Traumatic injury represents a leading cause of critical
illness, and respiratory failure is a common complication of
severe trauma [1]. Approximately 2% to 4% of persons
with trauma develop acute lung injury (ALI). More
significantly, crude mortality rates in trauma-associated
ALI approach 40% [2]. Appreciation of the potential factors
contributing to ALI in trauma, therefore, represents a major
focus of research.
Multiple factors help explain why individuals with trauma
face an increased risk for ALI. The initial traumatic injury
itself can promote a systemic inflammatory response
facilitating the development of ALI [3]. Furthermore, focal
chest trauma, whether blunt or penetrating, heightens the risk
for ALI [4,5]. Similarly, the presence of hemorrhagic shock
along with its treatment can potentiate ALI [1,6]. Thus, one
aspect of trauma resuscitation, namely, blood transfusion, is
independently linked to the development of ALI. Mechanis-
tically, stored blood accumulates proinflammatory sub-
stances during storage even after leukoreduction, which
may contribute to the development of ALI, independent of
the presence of shock [7-11].
The correlation between packed red blood cell (pRBC)
use and ALI suggests that a different strategy to trauma
resuscitation might alter rates of ALI. The use of warm fresh
whole blood (WFWB) is one potential alternative to pRBCs.
Fresh blood lacks many of the factors that comprise the
theoretical “storage lesion” found in stored pRBCs that have
been associated with ALI [12]. Early studies of WFWB use
suggest that it is a safe alternative in trauma resuscitation [13-
15]. These prior analyses, though, have not explored specific
complications associated with transfusion in trauma, nor
have they addressed ALI after trauma. Furthermore, the
absence of a mortality penalty related to the use of WFWB
relative to other components such as apheresis platelets
(aPLTs) does not preclude that WFWB itself might,
nonetheless, increase morbidity or other complications.
We hypothesized that WFWB represents a safe option
after trauma with respect to the potential for ALI.
Specifically, we theorized that exposure to WFWB would
decrease the risk for ALI in massive transfusion as compared
with resuscitation with component therapy including pRBCs.
To evaluate our hypothesis, we conducted a retrospective
analysis of a large military trauma registry reflecting the US
military experience in Iraq.
2. Materials and methods
2.1. Study overview
We retrospectively identified all patients with trauma (US
military, coalition troops, contractors, Iraqi police/military,
and Iraqi civilians) admitted to the Combat Support Hospital
in Ibn Sina Hospital in Baghdad, Iraq, between January 2004
and December 2006. The specific cohort of interest,
traumatic patients undergoing massive transfusion, has
been described in part elsewhere [16]. The initial study
creating the overall trauma registry at Ibn Sina was approved
by the institutional review board at Brooke Army Medical
Center in San Antonio, TX, and in accordance with the
approved protocol. This de-identified subgroup analysis was
exempted from institutional review board approval after
review from the Office of Research at the Uniformed
Services University of Health Sciences, Bethesda, MD.
During the study period, protocols that standardized the
transfusion practice in trauma resuscitation existed [17]. At
the Combat Support Hospital, physicians had access to
various blood products including pRBCs, fresh-frozen
plasma (FFP), and cryoprecipitate. Per the protocol,
administration of blood products ensued within minutes of
injury so as not to delay resuscitation efforts. All subjects in
this cohort received pRBCs, and those given WFWB were
transfused with a minimum 2 units of WFWB. These
components were obtained almost exclusively from the
United States via the Armed Services Blood Program Office.
Warm fresh whole blood (collected and stored at 22°C for no
longer than 24 hours) was donated by questionnaire-screened
healthy volunteers no more frequently than every 8 weeks.
Warm fresh whole blood units were nonleukoreduced, and
most WFWB collected was transfused within 8 hours of
collection [18]. Starting in November 2004, aPLTs were
collected by certified apheresis technologists or technicians
and performed strictly following the American Association
of Blood Banks and US Food and Drug Administration
guidelines using a mobile collection system (MCS+ 9000;
Haemonetics, Braintree, Mass) and were stored for up to 5
days at 20°C to 24°C.
2.2. Subjects
We included patients undergoing massive transfusion in
the current analysis. We defined massive transfusion as the
receipt of 10 or more units of blood within 24 hours. We
excluded the following: (1) patients treated initially at
forward surgical units/local hospitals before transfer to Ibn
Sina Hospital, (2) those who received their massive
transfusion on a day other than on admission (after the first
24 hours), and (3) patients who died within 30 minutes from
admission because WFWB required a minimum of 30
minutes to collect and process before transfusion. This latter
group was excluded to control for potential survival bias.
2.3. End points and covariates
The development of ALI after massive transfusion served
as our primary end point. The presence of ALI was based on
discharge International Classification of Disease (ICD-9)
codes: 518.82. Factors associated with the development of
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ALI after massive transfusion served as a secondary end
point. We recorded information regarding patient demo-
graphics (age, sex, race), initial vital signs, laboratory data,
and mechanism of injury (eg, blunt vs penetrating). Disease
severity was assessed via the revised Trauma Injury Severity
Score (TRISS). The TRISS was calculated based on location
of injury, age, physiologic characteristics, and type of
trauma. Furthermore, we evaluated the types of blood
products transfused and if the patient was given WFWB.
To determine if there were any potential biases involved that
may have driven preferential use of WFWB, we investigated
variables independently linked to WFWB exposure as part of
a tertiary, exploratory analysis.
Acute lung injury may be difficult to diagnose in patients
with blunt trauma because chest contusion may mimic ALI.
We therefore conducted a sensitivity analysis to address this
concern by repeating our analyses after excluding patients of
blunt trauma.
2.4. Statistics
Categorical variables were examined using the χ2 test,
whereas continuous variables were evaluated using the
Student t test when normally distributed. The Fisher exact
test was used for small sample sizes, and the Mann-Whitney
U test was used for nonparametric variables, as appropriate.
All tests were unpaired and 2 tailed, and a P value less than
.05 was assumed to represent statistical significance.
Using the results from the univariate analysis, a multivar-
iate logistic regression model was developed to determine
patient characteristics and blood components associated with
the occurrence of ALI. Covariates found to have a significant
relationship with ALI with P b .10 on univariate analysis, and
those found to affect the prevalence of ALI based on previous
studies [2,19] were included in the model. Variables were
assessed to address colinearity. Goodness of fit was assessed
using the Hosmer-Lemeshow test.
A similar multivariate logistic regression model was
developed to assess variables independently associated with
the use of WFWB. To analyze this model, WFWB was
converted from a continuous variable into a categorical
variable, where in those who received any WFWB were
compared with those who were never exposed to WFWB.
3. Results
The final cohort included 591 subjects (mean age, 28.0
± 8.1 years; mean ± SD TRISS, 2.2 ± 2.2), and the overall
mortality was 30.3%. Most of the cohort were men
(96.7%) and experienced penetrating trauma wounds
(92.6%). The following quantities were transfused in this
study: 11 715 U of pRBCs, 933 U of WFWB, 7062 of
FFP, and 4716 U of cryoprecipitate. All patients received
RBCs, and approximately one fourth received WFWB.
Acute lung injury developed in 11.2% of subjects; of
these, 34% received WFWB transfusions. In contrast,
among those who did not develop ALI, only 20% received
WFWB transfusions (P = .01).
3.1. Factors associated with ALI
Baseline characteristics of those who developed ALI
compared with those without ALI are documented in
Table 1. Patients with ALI received more units of WFWB
than individuals who did not develop ALI (mean, 3.0 vs
1.4; P = .003). However, increasing doses of WFWB did
not correlate with the development of ALI. Also, more
individuals experienced blunt trauma in the ALI group
and received an average of 2.3 L more of crystalloid
therapy (P = .005). The subjects did not differ with regard
to severity of illness, physiologic and laboratory findings,
and administration of other blood components or recom-
binant factor VIIa (rFVIIa).
In a multiple logistic regression model adjusting for
multiple covariates (Table 2), the use of WFWB remained
Table 1 Comparison between those who did and did not
develop ALI
ALI No
ALI
P
Demographic characteristics
Age (y), mean 28.9 27.9 .32
Sex, male (%) 98.5 97.5 .63
Trauma characteristics
Injury Severity Index, mean 26.0 24.2 .26
Revised Trauma Score, mean 6.5 6.3 .66
TRISS, median a 2.3 2.9 .19
Wound, penetrating (%) a 83.3 94.3 .001
Physiologic parameters (on admission)
Systolic blood pressure (mm Hg), mean 102.8 97.5 .26
Diastolic blood pressure (mm Hg), mean 56.6 54.2 .46
Heart rate (beats/min), mean 117.9 115.2 .48
Respiratory rate (breaths/min), mean 24.9 22.7 .10
Laboratory findings
Hemoglobin (g/dL), mean 11.5 11.0 .11
Platelet count (103/μL), mean 263.5 253.6 .54
International normalized ratio, mean 1.7 1.8 .70
pH, mean 7.2 7.2 .78
Base deficit, mean 9.8 9.6 .86
Transfused blood products within
24 h of trauma
WFWB (U), median a 3.0 1.4 .003
Red blood cells (U), mean 19.8 19.8 .98
Total RBC (U), RBC + WFWB 22.8 21.2 .36
FFP (U), mean a 13.4 11.8 .14
aPLTs (U) 1.2 1.4 .34
Other resuscitation measures
Crystalloid use within 24 h (L), median a 11.4 9.0 .005
rFVIIa (%) 57.8 60.5 .68
a Variables included in logistic regression model (Table 2).
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independently associated with the diagnosis of ALI. The
adjusted odds ratio (AOR) related to ALI when WFWB was
administered was 1.06 (95% confidence interval [CI], 1.00-
1.13; P = .044). Other variables significantly associated with
the development of ALI included the administration of
crystalloids (AOR, 1.05; 95% CI, 1.00-1.10; P = .040) and
the type of trauma, where blunt trauma conferred a higher
risk (AOR, 3.54; 95% CI, 1.61-7.77; P = .002).
Because blunt chest trauma causes pulmonary contusions,
which can be misdiagnosed as ALI, we conducted a
sensitivity analysis excluding these patients. Our findings
were similar in the penetrating trauma alone cohort where
increasing WFWB (AOR, 1.08; 95% CI, 1.02-1.14; P =
.010) and crystalloid (AOR, 1.06; 95% CI, 1.01-1.11; P =
.020) administration correlated with the occurrence of ALI
(Hosmer-Lemeshow test statistic = 0.299) [data otherwise
not shown].
3.2. Factors associated with WFWB use and
its prevalence
Approximately 66% of those who developed ALI never
received WFWB. The characteristics of those given WFWB
vs those resuscitated with pRBCs are shown in Table 3.
More patients who received WFWB were US citizens and
were more severely ill. Despite these differences, mortality
was similar between the 2 groups (41.5% in the WFWB
group vs 45.6% in the non-WFWB group, P = .466).
Table 4 reveals that severity of illness was significantly
associated with WFWB administration, even after adjusting
for covariates (AOR, 1.18; 95% CI, 1.02-1.35; P = .021).
Furthermore, US citizenship (AOR, 3.06; 95% CI, 1.74-5.37;
P b .0001), use of rFVIIa (AOR, 1.94; 95% CI, 1.06-3.57;
P = .032), and increasing use of crystalloid therapy (AOR,
1.12; 95% CI, 1.06-1.18; P b .0001) were associated with
the use of WFWB. Conversely, the transfusion of aPLT
was linked with fewer transfusions of WFWB (AOR, 0.72;
95% CI, 0.60-0.87; P = .001).
In the stratified analysis, the prevalence of ALI in those
who received any WFWB was approximately 18.0%
compared with only 9.3% in those who did not receive
Table 2 Independent factors associated with the development
of ALI
AOR 95% CI P
Whole fresh warm blood 1.06 1.00-1.13 .04
Wound, blunt 3.54 1.61-7.77 .002
Crystalloids 1.05 1.00-1.10 .04
FFP 0.99 0.96-1.03 .83
TRISS 1.03 0.89-1.18 .71
An AOR greater than 1 signified a higher risk for ALI. Thus, WFWB,
crystalloid therapy, and blunt trauma wounds were associated with ALI.
aHosmer-Lemeshow test (P = .201).
Table 3 Comparison of baseline characteristics between
WFWB and non-WFWB groups
WFWB No
WFWB
P
Demographic characteristics
Age (y), mean 27.6 28.1 .56
Sex, male (%) 96.9 97.8 .53
Citizenship, United States (%) a 60.2 35.0 b.0001
Trauma characteristics
Injury Severity Index, mean 27.5 23.5 .001
Revised Trauma Score, mean 6.0 6.5 .02
TRISS, median a 1.6 2.4 .001
Wound, penetrating (%) 92.9 93.1 .96
Physiologic parameters
Systolic blood pressure
(mm Hg), mean
92.2 99.6 .02
Diastolic blood pressure
(mm Hg), mean
48.2 56.2 .001
Heart rate (beats/min), mean 113.1 116.1 .34
Respiratory rate (breaths/min),
mean
23.0 23.0 .51
Temperature (°C), median a 36.3 36.4 .005
Laboratory findings
Hemoglobin (g/dL), mean a 10.5 11.2 .007
Platelet count (103/μL), meana 221.1 263.4 b.0001
INR, mean a 2.0 1.7 .003
pH, mean 7.1 7.2 b.0001
Base deficit (mEq/L), mean 11.8 9.0 b.0001
Transfused blood products within 24 h of trauma
Red blood cells (U), mean 22.6 19.1 .05
FFP (U), mean 13.8 11.4 .23
aPLTs (U), mean a 1.1 1.5 b.0001
Cryoprecipitate (U), mean 11.0 7.2 .02
Other resuscitation measures
Crystalloids (L), mean a 12.3 9.6 b.0001
rFVIIa (%) a 67.2 58.3 .07
Mortality
48-h mortality (%) 21.1 22.8 .69
30-d mortality (%) 41.5 45.6 .47
INR indicates international normalized ratio.
a Variables included in logistic regression model (Table 4).
Table 4 Independent factors related to the use of WFWB
AOR 95% CI P
TRISS 1.179 1.02-1.35 .02
aPLTs 0.720 0.60-0.87 .001
Crystalloids 1.122 1.06-1.18 b.0001
rFVIIa 1.943 1.06-3.57 .03
Citizenship, United States 3.058 1.74-5.37 b.0001
Temperature 0.881 0.71-1.10 .26
Hemoglobin 0.901 0.81-1.01 .07
INR 0.943 0.74-1.20 .63
Platelets 0.997 0.99-1.00 .09
INR indicates international normalized ratio.
An odds ratio greater than 1 demonstrated an increased rate of exposure
to WFWB. Severity of illness (TRISS), use of aPLTs, crystalloids, and
rFVIIa were all associated with WFWB use.
aHosmer-Lemeshow test (P = .254).
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WFWB. Within the WFWB group, there were no
significant risk factors associated with the development of
ALI (Table 5). However, in the subgroup that did not
receive any WFWB, the occurrence of ALI was again
found to be related to crystalloid therapy and type of
trauma wound (Table 6).
4. Discussion
This retrospective analysis of a large group of patients
with trauma requiring massive blood transfusions docu-
ments that the overall occurrence of ALI was low, but the
transfusion of WFWB may be associated with its
development. Our results suggest that WFWB transfusion
might increase morbidity when massive transfusion is
required. This relationship persisted even after controlling
for selected other risk factors for ALI, such as severity of
illness. In short, we cannot exclude the potential for harm
related to WFWB use.
Prior studies have evaluated the relationship between ALI
and the transfusion of various blood products. For example,
in a recent nested case-control study consisting of 2024
intensive care unit patients who had a length of intensive care
unit stay of more than 48 hours, 109 individuals developed
ALI [20]. When compared with controls, the volume of
platelets and plasma transfused was associated with ALI in a
univariate analysis, but this association disappeared in the
multivariate analysis. This contrasts prior epidemiologic
studies that implicated FFP, rather than other blood products,
as an independent risk factor for ALI [2,19,21]. In a
Table 5 Comparing characteristics associated with ALI in patients receiving WFWB and among those who are WFWB naïve
Prevalence of ALI (%) WFWB experienced (18.0) WFWB naïve (9.3)
ALI No ALI P ALI No ALI P
Demographic characteristics
Age (y), mean 28.7 27.4 .47 29.0 28.0 .42
Sex, male (%) 100.0 96.2 .34 97.7 97.9 .94
Type of trauma, penetrating (%) a 91.3 93.3 .74 79.1 94.5 .001
Trauma characteristics
Injury Severity Index, mean 28.8 27.2 .58 24.4 23.4 .60
Revised Trauma Score, mean 6.3 5.9 .39 6.5 6.5 .80
TRISS, median a 1.7 1.6 .74 2.4 2.4 .85
Physiologic parameters
Systolic blood pressure (mm Hg), mean 95.7 91.4 .61 106.6 98.9 .19
Diastolic blood pressure (mm Hg), mean 48.5 48.1 .93 60.7 55.7 .21
Heart rate (beats/min), mean 116.9 112.2 .49 118.4 115.9 .59
Respiratory rate (breaths/min), mean 26.7 22.2 .09 23.9 22.9 .49
Laboratory findings
Hemoglobin (g/dL), mean 11.5 10.3 .06 11.6 11.1 .31
Platelet count (103/μL), mean 212.3 223.0 .67 288.4 260.8 .16
INR, mean 2.2 2.0 .41 1.5 1.7 .43
pH, mean 7.1 7.2 .33 7.2 7.2 .41
Base deficit (mEq/L), mean 13.4 11.5 .29 7.9 9.1 .29
Transfused blood products within 24 h of trauma
Red blood cells (U), mean 22.7 22.6 .96 18.2 19.1 .55
FFP (U), mean 14.5 13.6 .71 12.7 11.3 .23
aPLTs (U) 0.9 1.2 .59 1.3 1.5 .62
Other resuscitation measures
Crystalloid use (L), mean a 13.5 12.0 .40 11.5 9.4 .02
rFVIIa (%) 63.6 68.0 .69 54.8 58.6 .63
Outcome measures
30-d mortality (%) 45.5 40.5 .67 50.0 45.1 .62
INR indicates international normalized ratio.
a Variables included in logistic regression model (Table 6).
Table 6 Independent risk factors associated with ALI in those
naïve to WFWB
OR 95% CI P
Wound, blunt 5.48 2.25-13.38 b.0001
TRISS 1.01 0.85-1.21 .88
Crystalloids 1.07 1.01-1.13 .02
aHosmer-Lemeshow test (P = .772).
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retrospective analysis focusing specifically on patients with
trauma, the authors noted a trend toward increased
respiratory failure in patients who received WFWB (7%)
compared with component therapy (3%, P = .08) [13]. In
addition, in a prospective observational study, the develop-
ment of ALI in patients with trauma was associated with
increasing transfusion of blood products. Using both the
strict American-European Consensus Conference criteria for
ALI and an equivocal definition where chest radiographs
were difficult to interpret yielded the same findings that
increasing units of blood were independently associated with
ALI [22].
Our findings add to prior analyses exploring the effect of
blood product transfusion on the development of ALI.
Specifically, our findings are novel in that we document that
both WFWB and crystalloid may be linked to ALI. The
correlation between crystalloid therapy and ALI after trauma
confirms several earlier reports examining damage control
resuscitation [23]. In multiple animal studies, preferential
administration of crystalloid therapy during hemorrhagic
shock exacerbates the systemic inflammatory response, thus
potentiating the risk for ALI [9,24]. Furthermore, aggressive
intravenous fluid replacement interferes with hemostatic
mechanisms that will exacerbate blood loss [23]. In
combination, our study supports these prior studies and
suggests that crystalloids should be judiciously administered
during the resuscitation process.
No prior analyses have explored how the use of WFWB
alters rates of ALI. Warm fresh whole blood has received
attention as an alternate to component therapy because in
some austere environments, select components of blood,
such as aPLT, may not be readily available. Similarly, some
suggest that WFWB may offer a relative safety advantage
because it has not undergone processing and storage.
Although our data suggest that WFWB may contribute to
ALI in ways similar to other transfusion components, the fact
that approximately 66% of individuals who developed ALI
were never exposed to WFWB underscores that one cannot
draw a firm causal connection betweenWFWB and ALI. The
relationship between WFWB and ALI is, thus, likely weak,
irrespective of the results of the logistic regression. On the
one hand, WFWB transfusion may represent a necessary but,
not of and within itself, sufficient step in the evolution of ALI
after massive transfusion. As a corollary, eliminating its use
would not necessarily lead to a decrease in the incidence of
ALI in trauma. Conversely, WFWB was administered to
sicker patients, and despite our efforts, we likely could not
completely adjust for severity of illness as a potential
confounder. In fact, more subjects in this subset also received
rFVIIa, indirectly suggesting more extensive bleeding. Thus,
we cannot exclude that the occurrence of ALI in this
population may be confounded by issues related to severity
of illness incompletely captured through TRISS. Indeed, the
trauma itself may be the culprit event that triggers the
evolution of ALI, and at worse, WFWB transfusions, or any
blood product exposure, simply fuel the fire [10].
There are several mechanisms by which WFWB could
precipitate ALI. First, the relatively large volume of plasma in
WFWB contains leukocyte antibodies, which have been
demonstrated to be associated with ALI [25]. Approximately
70% of individuals who receive WFWB during cardiac
surgery also have transfusion of living leukocytes. Forty
percent had leukoagglutinin formation, and another 30%
developed incomplete antibodies. These fresh living leuko-
cytes were distinct from leukocytes in stored blood and
possess intact transplantation antigens [11]. Second, transfu-
sion-associated microchimerism may occur where allogeneic
leukocytes replicate in the host. Clinical manifestations of the
chimerism can cause a graft-vs-host disease or an autoim-
mune process that precipitates ALI. Transfusion-associated
microchimerism occurs in nearly 50% of transfused severely
injured patients. More concerning, leukoreduction does not
affect the likelihood of its occurrence, and it happens more
frequently with younger fresher blood. These possibilities
could explain the higher incidence of ALI in those who
received WFWB in our cohort [26]. In essence, both WFWB
and component therapy mechanistically share features that
may potentiate the evolution of ALI.
Demonstrating the possibility that WFWB may cause
harm illustrates the necessity to carefully study WFWB and
future resuscitation measures. In the same vein, our
observations indicate that the emergence of advanced
blood products such as freeze-dried plasma or frozen
platelets mandates that clinical trials of these products, as
multiple regulations currently require, systematically collect
information regarding the possible morbidity associated with
ALI. Our results should not be interpreted as a call to prevent
further use of WFWB. Rather, it is likely that all blood
products, whether WFWB or component therapy, “fuel the
fire” and foster the evolution of ALI. Similarly, the true
contribution of WFWB to the burden of ALI after trauma is
likely limited, given the frequency with which ALI is seen in
those who are never exposed to WFWB.
Our study has several unique attributes. The cohort for
this study predominantly consisted of patients who had
penetrating trauma wounds as opposed to blunt trauma
injuries. This distinction affords us the ability to examine
lung injury because it pertains to penetrating wounds.
Because blunt trauma is certainly easier to confuse with
ALI because of the presence of pulmonary contusions,
specifically studying the effects of various types of traumatic
injuries helps us to control for confounding due to type of
injury. That WFWB remains linked to ALI development
after excluding those who experienced blunt trauma un-
derscores the possible relationship betweenWFWB and ALI.
This study is also unique because of the effort to standardize
the approach to manage patients with trauma requiring
massive blood transfusions. Treatment of these patients was
standardized and was minimally influenced by the physi-
cians employed or the patient's characteristics. In addition, a
standard approach to harvesting and testing WFWB was
available to ensure timely transfusion of fresh blood.
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There are several limitations to this study. First, as a
retrospective study, it is subject to many forms of bias.
Collection of data was not specific for this study and may
have been missing or misclassified. However, to minimize
this, other databases were searched to reconcile missing or
discrepant data. Second, we did not assess if the use of RBCs
contributed to the progression to lung injury and, therefore,
did not control for the effects of transfusion-related ALI
(TRALI) as a potential cause for ALI. The incidence of
TRALI is approximately 1 in every 5000 blood components
transfused [15]. Given the number of blood and blood
products transfused in this cohort, TRALI probably did not
significantly contribute as a cause for ALI. The incidence of
TRALI would be low and would not have affected our
analysis. Third, the diagnosis of ALI was based on discharge
ICD-9 coding, which is therefore dependent on the
physician's astuteness at diagnosing this disease process.
As a result, misclassification bias could have occurred. In
fact, prior evidence suggests that 8% to 40% of cases are
misdiagnosed based on ICD-9 coding, depending on the
diagnosis [27-29]. However, for ALI specifically, systemat-
ically auditing charts to determine the ability of ICD-9 coding
to identify the true incidence of ALI yields a sensitivity
ranging from 79% to 88% and a specificity of 98% to 99%
[30]. Fourth, the diagnosis of ALI was relatively uncommon,
occurring in only 11.2% of the entire cohort. Thus, this study
may be underpowered to truly assess risk factors associated
with ALI. This small sample size further limits our ability to
determine whether the development of ALI in this population
has any affect on mortality or if increasing exposure of
WFWB truly affected the development of ALI. Finally, most
subjects were young men who underwent penetrating trauma
injuries. As such, the results of this study may not be
generalizable to other patients with trauma who need massive
transfusion. However, the subjects were relatively young and
healthy when they acquired their trauma-induced injuries,
and the diagnosis of ALI was presumably less confounded by
other comorbid conditions or disease processes, which would
only exaggerate this correlation.
5. Conclusion
Freshwhole bloodmay be associatedwith an increased risk
of ALI in those who have traumatic injuries requiring massive
transfusion, but this is confounded by increased injury and
crystalloid use in patients receiving WFWB. The risk/benefit
ratio of WFWB must be carefully weighed before its
administration. Although the use of WFWB is lifesaving
when other components are not available, its potential to
increase morbidity must also be considered. Findings from
this hypothesis-generating study can be used to facilitate
further research in this field. To clarify the relationship
between WFWB and the development of ALI, a larger
prospective study to examine whether increasing exposure to
WFWB affects the risk for ALI would be warranted.
Unfortunately, a randomized controlled trial would not be
feasible because limiting such therapy to critically ill patients
with trauma would violate equipoise. In addition, diagnosing
ALI prospectivelywould decrease potential confounding from
misclassification bias. Certainly, given the importance of this
lifesaving therapy, research elucidating the potential harms
associated with WFWB administration must be prioritized to
adequately prevent and treat potential complications.
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